Cargando…

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

A recent “hot topic” in prostate cancer radiotherapy is the observed association between acute/late rectal toxicity and the presence of abdominal surgery before radiotherapy. The exact mechanism is unclear. Our working hypothesis was that a previous surgery may influence plasma level of inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bedini, Nice, Cicchetti, Alessandro, Palorini, Federica, Magnani, Tiziana, Zuco, Valentina, Pennati, Marzia, Campi, Elisa, Allavena, Paola, Pesce, Samantha, Villa, Sergio, Avuzzi, Barbara, Morlino, Sara, Visentin, Maria Emanuela, Zaffaroni, Nadia, Rancati, Tiziana, Valdagni, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845513/ https://www.ncbi.nlm.nih.gov/pubmed/29682101 http://dx.doi.org/10.1155/2018/9128128

Ejemplares similares

Eleven-year Management of Prostate Cancer Patients on Active Surveillance: What have We Learned?
por: Marenghi, Cristina, et al.
Publicado: (2017)

miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
por: El Bezawy, Rihan, et al.
Publicado: (2019)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
por: Gandellini, Paolo, et al.
Publicado: (2021)

Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?
por: Alvisi, Maria Francesca, et al.
Publicado: (2020)

Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy
por: Munoz, Fernando, et al.
Publicado: (2021)

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer
por: Doldi, Valentina, et al.
Publicado: (2022)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects
por: Bresolin, Andrea, et al.
Publicado: (2020)

Editorial: Modeling for Prediction of Radiation-Induced Toxicity to Improve Therapeutic Ratio in the Modern Radiation Therapy Era
por: Rancati, Tiziana, et al.
Publicado: (2021)

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
por: El Bezawy, Rihan, et al.
Publicado: (2017)

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair
por: El Bezawy, Rihan, et al.
Publicado: (2020)

Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning
por: Perna, Lucia, et al.
Publicado: (2011)

Modelling radiotherapy side effects: practical applications for planning optimisation
por: Rancati, Tiziana, et al.
Publicado: (2019)

‘Act on Oncology’ as a New Comprehensive Approach to Assess Prostate Cancer Centres – Method Description and Results of a Pilot Study
por: Voigt, Wieland, et al.
Publicado: (2014)

Stability of Multi-Parametric Prostate MRI Radiomic Features to Variations in Segmentation
por: Thulasi Seetha, Sithin, et al.
Publicado: (2023)

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression
por: Rotundo, Federica, et al.
Publicado: (2020)

Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients
por: Cavallo, Anna, et al.
Publicado: (2021)

miR-21: an oncomir on strike in prostate cancer
por: Folini, Marco, et al.
Publicado: (2010)

Towards spatial representations of dose distributions to predict risk of normal tissue morbidity after radiotherapy
por: Casares-Magaz, Oscar, et al.
Publicado: (2020)

Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
por: Palorini, Roberta, et al.
Publicado: (2013)

miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
por: Crippa, Elisabetta, et al.
Publicado: (2016)

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
por: Joseph, Nuradh, et al.
Publicado: (2022)

PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins
por: Zuco, Valentina, et al.
Publicado: (2015)

A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
por: Pavlin, Matic, et al.
Publicado: (2018)

δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
por: Fontana, Fabrizio, et al.
Publicado: (2021)

The Normal, the Radiosensitive, and the Ataxic in the Era of Precision Radiotherapy: A Narrative Review
por: Pereira, Sandrine, et al.
Publicado: (2022)

Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective
por: Possenti, Luca, et al.
Publicado: (2021)

Survivin is Highly Expressed and Promotes Cell Survival in Malignant Peritoneal Mesothelioma
por: Zaffaroni, Nadia, et al.
Publicado: (2007)

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts
por: De Cesare, Michelandrea, et al.
Publicado: (2016)

Radiotherapy-induced ferroptosis for cancer treatment
por: Beretta, Giovanni L., et al.
Publicado: (2023)

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
por: Zuco, Valentina, et al.
Publicado: (2011)

Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
por: Marvaso, Giulia, et al.
Publicado: (2021)

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
por: Doldi, Valentina, et al.
Publicado: (2015)

The simulation-CT: Radiotherapy’s useful tool in the race against COVID-19 pandemic. A serendipity approach()
por: Vitullo, Angelo, et al.
Publicado: (2020)

A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
por: Massi, Michela Carlotta, et al.
Publicado: (2020)

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
por: Franco, Nicola Rares, et al.
Publicado: (2021)

Characterization of stress response in human retinal epithelial cells
por: Giansanti, Vincenzo, et al.
Publicado: (2013)

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
por: Alessandrini, Irene, et al.
Publicado: (2022)

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
por: Webb, Adam J., et al.
Publicado: (2022)

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife
por: Descovich, Martina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_14jas1jngqovifm3f07fjjb9fb